Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

13.55
Delayed Data
As of Apr 25
 0.00 / 0.00%
Today’s Change
7.75
Today|||52-Week Range
36.33
+2.26%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Wilkinson George Frederick
Chief Executive Officer
Sale4/29/201697,219$33.35$3.2M-59.37%
Benet Leslie Z
Director
Sale8/15/201610,092$22.81$230.2K-41.01%
Benet Leslie Z
Director
Buy8/15/201620,000$6.55$131.0K-41.01%
Nestor Michael J
Sale5/15/20163,236$29.18$94.4K-55.01%
Nestor Michael J
Sale5/14/20163,003$29.18$87.6K-55.01%
Schlossberg Mark A /impax/
General Counsel & Senior Vice President
Sale2/26/20176,014$14.05$84.5K-7.51%
Reasons Bryan M
Chief Financial Officer
Sale2/26/20175,715$14.05$80.3K-7.51%
Nestor Michael J
Sale2/26/20175,594$14.05$78.6K-7.51%
Schlossberg Mark A /impax/
General Counsel & Senior Vice President
Sale5/15/20162,330$29.18$68.0K-55.01%
Schlossberg Mark A /impax/
General Counsel & Senior Vice President
Sale5/14/20162,163$29.18$63.1K-55.01%
Page of 4